NCT01262885 arm group 6e20f3bb02cb04e8cdceb92b33999c70 [clinicaltrials_resource:NCT01262885/arm-group/6e20f3bb02cb04e8cdceb92b33999c70]
Placebo [clinicaltrials_resource:08f23b3f757e6225a664ad26f2a3fc3c]GSK2251052 [clinicaltrials_resource:1987a2dab4e4b5dbd80fb528c299adf6]A Randomized, Single Blind, Placebo Controlled Study to Evaluate Safety, Tolerability, and Pharmacokinetics of Single Oral Doses and Repeat Escalating Oral Doses of GSK2251052 in Healthy Adult Subjects [clinicaltrials:NCT01262885]
arm group [clinicaltrials_vocabulary:arm-group]
NCT01262885 arm group 6e20f3bb02cb04e8cdceb92b33999c70 [clinicaltrials_resource:NCT01262885/arm-group/6e20f3bb02cb04e8cdceb92b33999c70]
Bio2RDF identifier
NCT01262885/arm-group/6e20f3bb02cb04e8cdceb92b33999c70
Bio2RDF namespace
clinicaltrials_resource
Bio2RDF uri
http://bio2rdf.org/clinicaltri ...... 20f3bb02cb04e8cdceb92b33999c70
description [clinicaltrials_vocabulary:description]
GSK2251052 2000 mg (6 subjects), Placebo (1 subject)
identifier
clinicaltrials_resource:NCT01262885/arm-group/6e20f3bb02cb04e8cdceb92b33999c70
title
NCT01262885 arm group 6e20f3bb02cb04e8cdceb92b33999c70
@en
type
label
NCT01262885 arm group 6e20f3bb ...... 0f3bb02cb04e8cdceb92b33999c70]
@en